98%
921
2 minutes
20
Advanced cell culture systems including human induced pluripotent stem (iPS) cells and organoids enable the generation of intricate structural and functional organ models in vitro. Application of these advanced cell culture systems to research on a wide range of diseases including infectious diseases is underway. Due to the impact of the coronavirus disease 2019 (COVID-19) pandemic, advanced cell culture systems in the virus research field are rapidly becoming popular. Respiratory models generated using human iPS cells and organoid technology are useful for analyzing respiratory cell responses caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, there is still room for the development of an apical-out model, which is essential for simple virus infection experiments, and a model that can analyze host responses in the alveoli and airways. In this study, we developed human iPS cell-derived alveolar and airway models with an apical-out structure by using a micropatterning plate. In the alveolar model, we confirmed that this model contains abundant type II alveolar epithelial (AT2) cells, which are the target cells of SARS-CoV-2 in the alveoli. In the airway model, we confirmed that this model contains abundant ciliated cells, which are the target cells of SARS-CoV-2 in the airway. Using our alveolar and airway models, we can analyze the differences in infection efficiency and host response of each SARS-CoV-2 variant. We hope that the human iPS cell-derived alveolar and airway models generated using a micropatterning plate will be used to analyze not only SARS-CoV-2 but also a wide range of respiratory viruses.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2222/jsv.74.35 | DOI Listing |
Allergol Immunopathol (Madr)
September 2025
Corporación Universitaria Rafael Núñez, Ginumed, Cartagena, Colombia;
Human proteinase 3 (hPR3) is a lysosomal enzyme of the serine protease type. In autoimmune vasculitis, autoantibodies to hPR3 appear to have a role in the inception of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), where this protein is the main autoantigen. Indeed, patients with antibodies against hPR3 have more severe symptoms, relapses, and resistance to immunosuppressive therapies, supporting an important role for this autoantigen in the pathophysiology and severity of AAV.
View Article and Find Full Text PDFJ Health Organ Manag
September 2025
EL-IPS European Lab for Innovative Purchasing and Supply, University of Twente, Enschede, The Netherlands.
Purpose: The COVID-19 pandemic exposed critical vulnerabilities in healthcare systems, particularly in hospital procurement and preparedness for supply chain disruptions. This study aims to investigate how healthcare procurement professionals can develop sustainable preparedness plans for future supply disruptions.
Design/methodology/approach: A case study approach was adopted in this research.
Sci Rep
September 2025
Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.
If iPS cells can be established easily and efficiently using freshly collected blood cells, it will enhance regenerative and personalized medicine. While reports of iPS derivation from blood-derived endothelial progenitor cells using RNA have been documented, none have been reported from peripheral blood-derived mononuclear cells (PBMCs). In this study, we established a method to generate iPS cells from PBMCs using synthetic RNAs and found that MDM4, which suppresses p53, improved reprogramming efficiency.
View Article and Find Full Text PDFFront Immunol
September 2025
Wound Healing Center, Peking University Third Hospital, Beijing, China.
Background And Objective: Melanoma exhibits profound biological complexity, driven by immune evasion, phenotypic plasticity, and resistance to therapy. While programmed cell death (PCD) shapes tumor-immune interactions, its mechanistic landscape in melanoma remains incompletely defined. This study aims to comprehensively characterize PCD-related signatures and their associations with tumor heterogeneity, prognosis, and immunotherapeutic outcomes.
View Article and Find Full Text PDFNeural Regen Res
September 2025
Institute of Anatomy and Cell Biology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Human induced pluripotent stem cell-derived neural stem/progenitor cells are used in cell-replacement and regenerative therapeutic strategies after traumatic central nervous system injury. Traumatic injury alters the host microenvironment, which in turn affects the functionality of transplanted human neural stem/ progenitor cells and potentially limits their benefits for neurorepair. However, the underlying mechanisms through which the host environment alters the fate and functionality of transplanted human neural stem/progenitor cells remain poorly understood.
View Article and Find Full Text PDF